Skip to main content
Quest Diagnostics

Beyond the hype: Where genomics is having an impact on outcomes

Date: Tuesday, Nov 27, 2018
Description: During this webinar you’ll learn more about the rapid progress being made in linking genetic testing and personalized medicine to better health outcomes. From oncology to neurological disorders like Alzheimer’s disease, the speakers discuss the diseases that are seeing the greatest potential and those areas that are still emerging.

Authors: 

James, Patrick, MD
Chief Clinical Officer
Health Plans and Policy
Quest Diagnostics

Lacbawan, Felicitas, MD, FCAP, FACM
Executive Medical Director, Advanced Diagnostics
Quest Diagnostics, San Juan Capistrano, CA

Quinn, Bruce, MD, PhD
Principal
Bruce Quinn Associates LLC

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.